BPM
ALXN

Bowling Portfolio Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bowling Portfolio Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,504
Closed -$276K – 204
2021
Q2 		$276K Sell
1,504
-352
-19% -$60.4K 0.06% 186
2021
Q1 		$284K Sell
1,856
-8,626
-82% -$1.33M 0.07% 189
2020
Q4 		$1.64M Sell
10,482
-776
-7% -$99.7K 0.38% 71
2020
Q3 		$1.29M Sell
11,258
-13,465
-54% -$1.45M 0.29% 83
2020
Q2 		$2.77M Sell
24,723
-442
-2% -$46.9K 0.59% 36
2020
Q1 		$2.26M Sell
25,165
-1,764
-7% -$173K 0.56% 33
2019
Q4 		$2.91M Sell
26,929
-1,609
-6% -$172K 0.5% 49
2019
Q3 		$2.79M Buy
+28,538
New +$3.22M 0.47% 62

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Bowling Portfolio Management's ALXN Position: Q3 2021 in Review

Bowling Portfolio Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,504 shares — an estimated $276K sold.

Bowling Portfolio Management first reported a position in ALXN in Q3 2019 and held it in 8 quarters. The position peaked at $2.91M in Q4 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Bowling Portfolio Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Bowling Portfolio Management sold 1,504 Alexion Pharmaceuticals shares in Q3 2021, an estimated $276K.
  • Bowling Portfolio Management first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 8 quarters.
  • Bowling Portfolio Management's Alexion Pharmaceuticals position peaked at $2.91M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Bowling Portfolio Management's 13F filing for Q3 2021, filed 21 Oct 2021.